Lantheus extends Mo-99 deal with Nordion

Lantheus Medical Imaging has extended its contract with Nordion through 2013 for the continued supply of molybdenum-99 (Mo-99).

The original supply agreement between Lantheus and the Ottawa, Ontario-based Nordion was in place until July 31.

Mo-99 is the parent isotope of technetium-99m (Tc-99m), the most widely used medical radioisotope for molecular and nuclear diagnostic imaging procedures. Mo-99 is used in Lantheus’ TechneLite (Technetium Tc99m Generator) generators, according to the North Billerica, Mass.-based Lantheus.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.